Agomelatine might be more appropriate for elderly, depressed, type 2 diabetes mellitus patients than paroxetine/fluoxetine

Agomelatine was a novel and melatonergic antidepressant. The present study was conducted to find out whether age was an important factor for agomelatine in treating depressed type 2 diabetes mellitus (T2DM) patients. In total, 193 depressed T2DM patients were included. There were 84 patients ranged...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Zihong, Jia, Yanbo, Zhao, Lizhen, Zhu, Runxiu, He, Xuemei, Tong, Bagen, Yang, Fan, Hao, Lixia, Cui, Pengfei, Yuan, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8544326/
https://www.ncbi.nlm.nih.gov/pubmed/34610580
http://dx.doi.org/10.18632/aging.203586

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8544326/
https://www.ncbi.nlm.nih.gov/pubmed/34610580
http://dx.doi.org/10.18632/aging.203586

Ejemplares similares